Calcium-Polystyrene-Sulfonate shortage — CA supply status & alternatives

Calcium-Polystyrene-Sulfonate

—

In supply · Australia

CALCIUM RESONIUM calcium polystyrene sulfonate powder can

In supply · 🇦🇺 Australia · short in🇨🇦 CA🇺🇸 US🇳🇿 NZ🇧🇪 BE

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes

Active ingredient (INN)	Calcium-Polystyrene-Sulfonate
Brand names	CALCIUM RESONIUM calcium polystyrene sulfonate powder can
Therapeutic category	Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper
Controlled substance	No
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇺🇸

United States

FDA MedWatch · 1mo ago

High

🇨🇦

Canada

HC · 10h ago

High

🇳🇿

New Zealand

Pharmac · 10d ago

High

🇫🇷

France

ANSM · 2mo ago

Resolved

🇧🇪

FAMHP · 3mo ago

Medium

🇦🇺

Australia

TGA · 2mo ago

Resolved

🇸🇬

Singapore

HSA-SG · 4mo ago

Resolved

Verified timeline regulator events

🇨🇦 13 Aug 2026

high reported

🇧🇪 3 Mar 2026

medium reported

🇦🇺 29 Jan 2026

Shortage resolved

🇳🇿 21 Jan 2026

high reported

🇨🇦 16 Jan 2026

medium reported

🇨🇦 26 Nov 2025

medium reported

Sources official regulators

🇺🇸

FDA

verified just now

verify ↗

🇨🇦

verified 10h ago

verify ↗

🇳🇿

Pharmac

verified 10d ago

verify ↗

🇺🇸

FDA MedWatch

verified 1mo ago

verify ↗

🇦🇺

TGA

verified 2mo ago

verify ↗

🇫🇷

ANSM

verified 2mo ago

verify ↗

🇧🇪

FAMHP

verified 3mo ago

verify ↗

🇸🇬

HSA-SG

verified 4mo ago

verify ↗

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.